Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2004]

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights...

Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights blinatumomab benefits in key high-risk molecular types ( Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA )

Tec-Dara significantly improves PFS and OS compared to SoC in relapsed...

Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA

$Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma ( Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA )$

Racial disparities in AML: Black patients show inferior survival despite...

Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine...

Racial disparities in AML: Black patients show inferior survival despite similar cytogenetics and treatment response ( Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine, Baltimore, USA )

Asciminib shows high molecular response, favourable safety in 2L CML-CP

Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA

Asciminib shows high molecular response, favourable safety in 2L CML-CP ( Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA )

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and...

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive...

Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center...

Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses ( Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center, Houston, USA )

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG

Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG ( Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA )

The hidden biology of addiction and cancer

Prof Raphael Cuomo - UC San Diego School of Medicine, San Diego, USA

The hidden biology of addiction and cancer ( Prof Raphael Cuomo - UC San Diego School of Medicine, San Diego, USA )

Independent clones in CLL show oligoclonality and early evolution patterns

Dr Ferran Nadeu - August Pi i Sunyer Biomedical Research Institute, Barcelona...

Independent clones in CLL show oligoclonality and early evolution patterns ( Dr Ferran Nadeu - August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain )

Odronextamab shows durable efficacy in R/R follicular lymphoma: 2-Year ELM-2...

Prof Stefano Luminari - University of Modena and Reggio Emilia, Modena, Italy

Odronextamab shows durable efficacy in R/R follicular lymphoma: 2-Year ELM-2 phase 2 results ( Prof Stefano Luminari - University of Modena and Reggio Emilia, Modena, Italy )

Bexmarilimab plus azacitidine shows promising response in relapsed/refractory...

Dr Anthony Stein - City of Hope, Duarte, USA

$Bexmarilimab plus azacitidine shows promising response in relapsed/refractory myelodysplasia ( Dr Anthony Stein - City of Hope, Duarte, USA )$

More from ecancer